Ejada System News Today

Full year 2023 revenue of $6.3 billion, up 1% as-reported and 3% at constant currency Full year 2023 diluted earnings per share of $3.99 and non-GAAP Adjusted diluted earnings per share of...

An intrauterine vacuum-induced hemorrhage-control device provided prompt and effective management of bleeding in cases of obstetric hemorrhage.

14.09.2023 - Organon (NYSE: OGN), a global healthcare company focused on improving women’s health, today announced that Obstetrics & Gynecology (“The Green Journal”), the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), ...

The first WNY patient to be saved by a new device to stop a hemorrhage after childbirth returned to the hospital with her baby one year later to thank her doctors.

The Ministry of Labour announced the approval of a system of incentives and gratuities for all departments linked to Ejada System, as well as rewards for outstanding performers (workers) who excelled during 2022.

Device is safe and effective in real-world setting, providing high treatment success for vaginal and cesarean births.

FRIDAY, Feb. 17, 2023 (HealthDay News) -- The Jada System, an intrauterine vacuum-induced hemorrhage control device, is safe and effective in a real-world setting, according to a study presented at

Will an intrauterine vacuum-induced hemorrhage control device replace balloon tamponade as a mainstay of treatment for postpartum hemorrhage?

Muscat - H E Dr Mahad bin Said Ali Ba’owain, Minister of Labour, has issued a decision (No 36/2023) approving a unified system for evaluating the performance of employees of the state administrative apparatus.

Muscat: The Ministry of Labor has launched a unified system for measuring the job performance of all employees of the state administrative apparatus,...